Skip to content

Drug interactions

Daunorubicin + Ivacaftor

Severity: Moderate

Daunorubicin and Ivacaftor: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivacaftor and its M1 metabolite weakly inhibit P-glycoprotein and may raise levels of P-gp substrates. Daunorubicin toxicity such as myelosuppression could be increased, though clinical data are lacking.

What this interaction means in plain words

Daunorubicin and Ivacaftor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Daunorubicin belongs to Oncology; Ivacaftor belongs to Miscellaneous.

Evidence level: Low

Why it happens

Ivacaftor inhibits P-gp-mediated efflux of daunorubicin.

What to do

Monitor blood counts and cardiac function; reduce daunorubicin dose if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daunorubicin and Ivacaftor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Daunorubicin with Ivacaftor?

MediHelp rates the interaction as moderate. Daunorubicin and Ivacaftor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ivacaftor and its M1 metabolite weakly inhibit P-glycoprotein and may raise levels of P-gp substrates. Daunorubicin toxicity such as myelosuppression could be increased, though clinical data are lacking.

How serious is the interaction between Daunorubicin and Ivacaftor?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac function; reduce daunorubicin dose if toxicity occurs.

What other medicines interact with Daunorubicin?

MediHelp also lists interactions of Daunorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclosporine. The full list is on the Daunorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in